计划生育市场报告

DECEMBER 2025 CONTENTS ACRONYMS4 INTRODUCTION5 EXECUTIVE SUMMARY8 SUPPLIER SHIPMENT ANALYSIS HIGHLIGHTS FROM DISCUSSIONS WITH KEY STAKEHOLDERS CONCLUDING REMARKS33 ABOUT PARTICIPATING SUPPLIERS ACKNOWLEDGMENTS The Clinton Health Access Initiative (CHAI) and the Reproductive Health Supplies Coalition (RHSC) published the firstFamily Planning Market Report in 2015 as part of the FP2020 Global Markets Visibility Project. It initially covered 69FP2020 focus countries and in 2021, it expanded under the FP2030 global partnership and measurement structure toinclude all low- and lower-middle income countries, and now reports on 85 countries. Whereas the 2015 report featured Suppliers’ shipment data is the foundation of this report’s analyses, allowing CHAI and RHSC to address informationgaps and construct a comprehensive view of the reproductive health commodities market. We would like to thankcurrent participating suppliers: Bayer, Cipla, Corporate Channels, CR Zizhu, Cupid, Female Health Company, Incepta, We would also like to thank our colleagues from Avenir Health, FP2030, the United Nations Population Fund (UNFPA),and the Global Family Planning Visibility and Analytics Network (VAN) managed by RHSC2for their invaluablefeedback during the development and refinement of various market analyses. In past years, the Global Health SupplyChain Program – Procurement and Supply Management (GHSC-PSM) and the United States Agency for InternationalDevelopment (USAID) provided important inputs and data that strengthened the report. Due to the recent dismantling CHAI’s work on this report has been funded by UK International Development from the UK government; however, theviews expressed in this report do not necessarily reflect the UK government’s official policies. RHSC would like to thank ACRONYMS INTRODUCTION The Family Planning (FP) Market Report has beenproduced and published by the Clinton Health AccessInitiative (CHAI) and the Reproductive Health SuppliesCoalition (RHSC) annually since 2015 to enhancevisibility into the contraceptive commodities market.The report provides insights into public-sector community announced by FP2030 in 2021. This year, thereport includes data for 85 in-scope countries7from There are four key sections within this report: 1.Supplier shipment analysis: This section isthe primary focus of the report and includesan analysis of key public-sector contraceptiveprocurement trends from 2020 to 2024 basedon historical shipment data shared by the 18 For many years, USAID has served as a major procurerin the global contraceptive market enabling affordableaccess across many low- and lower-middle-incomecountries. Its dismantling in early 2025 representsa major inflection point for the FP ecosystem andhighlights the need for sustained visibility and Market volumes (in units), which are shareddirectly by suppliers, providing insight intohow contraceptive procurement for specific Market value (in USD),9which is calculatedby multiplying shipment volumes by methodwith the relevant average commodity priceseach year as per UNFPA’s Contraceptive Price The report analyzes procurement trends for dominantproduct-based modern methods of contraception,including implants, copper and hormonal4intrauterinedevices (IUDs), oral contraceptives (combined and Couple-years of protection (CYPs)shipped,which are calculated by multiplying shipmentvolumes by method with the relevant CYPconversion factor for each method. The CYP Historically, the FP Market Report covered the 69 FP2020focus countries. However, since 2022, the Market Reportcovers the broader set of all low- and lower-middle 3For simplicity, SMOs have been included in the public-sector scope for this report given that they have historically had notable donor-funded and/or subsidized volumes, andalso often support public-sector contraceptive programs in country. However, this is a simplified characterization given that SMOs also sometimes distribute products throughcommercial, non-subsidized channels depending on the country. CHAI and RHSC will continue to evaluate the best way to capture SMOs volumes in future family planningmarket reports based on available data.4Hormonal IUDs were included in the FP Market Report for the first time in 2022 since a publicly available hormonal IUD price was available for the first time that year in the 2021UNFPA Contraceptive Price Indicator to inform market value calculations.5Injectables data in the FP Market Report includes both DMPA-IM and DMPA-SC. Since DMPA-SC (Sayana Press) is currently produced by a single manufacturer, DMPA-IM andDMPA-SC volumes are reported together in this report (rather than broken down separately) to maintain supplier confidentiality6While some methods (e.g., male and female condoms and emergency contraceptives) may be used simultaneously with other methods, they have been displayed separatelythroughout this report for clarity.7As agreed upon with FP2030, each year an assessmen